TY - JOUR
T1 - Evidence-informed vaccination decision-making in countries
T2 - Progress, challenges and opportunities
AU - Steffen, Christoph A.
AU - Henaff, Louise
AU - Durupt, Antoine
AU - Omeiri, Nathalie El
AU - Ndiaye, Sidy
AU - Batmunkh, Nyambat
AU - Liyanage, Jayantha B.L.
AU - Hasan, Quamrul
AU - Mosina, Liudmila
AU - Jones, Ian
AU - O'Brien, Katherine
AU - Hombach, Joachim
N1 - Publisher Copyright:
© 2021 The Authors
PY - 2021/4/8
Y1 - 2021/4/8
N2 - Countries face an increasingly complex vaccination landscape. As well as ever-changing infectious disease epidemiology, the number and diversity of vaccine-preventable diseases, vaccine products, and vaccine technologies continue to increase. To ensure that vaccination decision-making is transparent, country-owned and informed by sound scientific evidence, many countries have established national immunization technical advisory groups (NITAGs) to provide independent expert advice. The past decade has seen substantial growth in NITAG numbers and functionality, and there is now a need to consolidate this progress, by further capacity building, to ensure that NITAGs are responsive to the changing face of immunization over the next decade.
AB - Countries face an increasingly complex vaccination landscape. As well as ever-changing infectious disease epidemiology, the number and diversity of vaccine-preventable diseases, vaccine products, and vaccine technologies continue to increase. To ensure that vaccination decision-making is transparent, country-owned and informed by sound scientific evidence, many countries have established national immunization technical advisory groups (NITAGs) to provide independent expert advice. The past decade has seen substantial growth in NITAG numbers and functionality, and there is now a need to consolidate this progress, by further capacity building, to ensure that NITAGs are responsive to the changing face of immunization over the next decade.
KW - Evidence-based decision-making
KW - Immunization programme
KW - NITAG
KW - National immunization technical advisory group
UR - http://www.scopus.com/inward/record.url?scp=85102259940&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102259940&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2021.02.055
DO - 10.1016/j.vaccine.2021.02.055
M3 - Article
C2 - 33712350
AN - SCOPUS:85102259940
SN - 0264-410X
VL - 39
SP - 2146
EP - 2152
JO - Vaccine
JF - Vaccine
IS - 15
ER -